Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design DOI
Alistaire D. Ruggiero, Ravichandra Vemuri,

Megan Blawas

и другие.

GeroScience, Год журнала: 2023, Номер 45(5), С. 2785 - 2803

Опубликована: Июнь 1, 2023

Язык: Английский

Biomarkers of aging DOI Open Access

Hainan Bao,

Jiani Cao, Mengting Chen

и другие.

Science China Life Sciences, Год журнала: 2023, Номер 66(5), С. 893 - 1066

Опубликована: Апрель 11, 2023

Язык: Английский

Процитировано

194

Tumor biomarkers for diagnosis, prognosis and targeted therapy DOI Creative Commons
Yue Zhou, Lei Tao, Jiahao Qiu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Май 20, 2024

Abstract Tumor biomarkers, the substances which are produced by tumors or body’s responses to during tumorigenesis and progression, have been demonstrated possess critical encouraging value in screening early diagnosis, prognosis prediction, recurrence detection, therapeutic efficacy monitoring of cancers. Over past decades, continuous progress has made exploring discovering novel, sensitive, specific, accurate tumor significantly promoted personalized medicine improved outcomes cancer patients, especially advances molecular biology technologies developed for detection biomarkers. Herein, we summarize discovery development including history conventional innovative used biomarker classification biomarkers based on tissue origins, application clinical management. In particular, highlight recent advancements biomarker-based anticancer-targeted therapies emerging as breakthroughs promising strategies. We also discuss limitations challenges that need be addressed provide insights perspectives turn into opportunities this field. Collectively, multiple emphasized review may guidance precision medicine, broaden horizons future research directions, expedite patients according their rather than organs origin.

Язык: Английский

Процитировано

134

Aging and chronic inflammation: highlights from a multidisciplinary workshop DOI Creative Commons
Danay Saavedra, Ana Laura Añé-Kourí, Nir Barzilai

и другие.

Immunity & Ageing, Год журнала: 2023, Номер 20(1)

Опубликована: Июнь 8, 2023

Aging is a gradual, continuous series of natural changes in biological, physiological, immunological, environmental, psychological, behavioral, and social processes. entails the immune system characterized by decrease thymic output naïve lymphocytes, an accumulated chronic antigenic stress notably caused infections such as cytomegalovirus (CMV), cell senescence with acquisition inflammatory senescence-associated secretory phenotype (SASP). For this reason, due to SASP originating from other tissues, aging commonly accompanied low-grade inflammation, termed "inflammaging". After decades accumulating evidence regarding age-related processes domain now appears mature enough allow integrative reinterpretation old data. Here, we provide overview topics discussed recent workshop "Aging Chronic Inflammation" which many major players field contributed. We highlight advances systematic measurement interpretation biological markers aging, well their implications for human health longevity interventions that can be envisaged maintain or improve function older people.

Язык: Английский

Процитировано

77

Cardiovascular disease and cancer: shared risk factors and mechanisms DOI
Nicholas S. Wilcox,

Uri Amit,

Jacob B. Reibel

и другие.

Nature Reviews Cardiology, Год журнала: 2024, Номер 21(9), С. 617 - 631

Опубликована: Апрель 10, 2024

Язык: Английский

Процитировано

68

Microglia regulation of central nervous system myelin health and regeneration DOI
Sarah Kent, Véronique E. Miron

Nature reviews. Immunology, Год журнала: 2023, Номер 24(1), С. 49 - 63

Опубликована: Июль 14, 2023

Язык: Английский

Процитировано

60

Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets DOI Open Access
José I. Erices, Carolina Bizama, Ignacio Niechi

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(8), С. 7047 - 7047

Опубликована: Апрель 11, 2023

Glioblastoma (GBM) is the most common and malignant primary brain cancer in adults. Without treatment mean patient survival approximately 6 months, which can be extended to 15 months with use of multimodal therapies. The low effectiveness GBM therapies mainly due tumor infiltration into healthy tissue, depends on cells’ interaction microenvironment (TME). cells TME involves cellular components such as stem-like cells, glia, endothelial non-cellular extracellular matrix, enhanced hypoxia, soluble factors adenosine, promote GBM’s invasiveness. However, here we highlight role 3D patient-derived glioblastoma organoids cultures a new platform for study modeling In this review, mechanisms involved GBM-microenvironment are described discussed, proposing potential prognosis biomarkers therapeutic targets.

Язык: Английский

Процитировано

56

Obesity-related kidney disease: Beyond hypertension and insulin-resistance DOI Creative Commons
Tarek Ziad Arabi, Areez Shafqat, Belal Nedal Sabbah

и другие.

Frontiers in Endocrinology, Год журнала: 2023, Номер 13

Опубликована: Янв. 16, 2023

Chronic kidney disease (CKD) causes considerable morbidity, mortality, and health expenditures worldwide. Obesity is a significant risk factor for CKD development, partially explained by the high prevalence of diabetes mellitus hypertension in obese patients. However, adipocytes also possess potent endocrine functions, secreting myriad cytokines adipokines that contribute to insulin resistance induce chronic low-grade inflammatory state thereby damaging kidney. development itself associated with various metabolic alterations exacerbate adipose tissue dysfunction resistance. This adipose-renal axis major focus current research, given rising incidence obesity. Cellular senescence biologic hallmark aging, age another obesity CKD. An elevated senescent cell burden predicts renal animal models, senotherapies may alleviate these phenotypes. In this review, we discuss direct mechanisms which contributes emphasizing potential clinical importance such pathways augmenting care

Язык: Английский

Процитировано

46

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity DOI Creative Commons
Siyao Li, Man J. Livingston,

Zhengwei Ma

и другие.

JCI Insight, Год журнала: 2023, Номер 8(8)

Опубликована: Март 14, 2023

Cisplatin is a widely used chemotherapy drug but it induces both acute and chronic kidney diseases (CKD) in cancer patients. The pathogenesis of cisplatin-induced CKD unclear effective renoprotective approaches are not available. Here, we report that repeated low-dose cisplatin (RLDC) treatment C57BL/6 mice induced cellular senescence tubules, accompanied with tubular degeneration pro-fibrotic phenotype transformation culminated maladaptive repair renal fibrosis. Suppression by senolytic drugs ABT-263 Fisetin attenuated fibrosis improved as indicated restoration regeneration function. In vitro, RLDC also mouse proximal BUMPT cells. eliminated senescent cells following treatment, reversed the increased their clonogenic activity. Moreover, alleviated paracrine effect RLDC-treated on fibroblasts for Consistently, knockdown p16 suppressed post-RLDC fibrotic changes cells, effects fibroblast proliferation. These results indicate persistent induction plays an important role promoting CKD. Targeting may be efficient to improve prevention

Язык: Английский

Процитировано

46

Lysosomes in senescence and aging DOI
Xiaojun Tan, Toren Finkel

EMBO Reports, Год журнала: 2023, Номер 24(11)

Опубликована: Окт. 9, 2023

Язык: Английский

Процитировано

46

Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases DOI

Qing Zeng,

Yongzhen Gong,

Neng Zhu

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 97, С. 102294 - 102294

Опубликована: Апрель 5, 2024

Язык: Английский

Процитировано

33